News & Analysis on Clinical Trial Services & Contract Research And Development
Chemicals major BASF managed to post a small gain in third quarter revenues despite the difficult operating environment affecting the industry; chairman Hambrecht points to early signs that the sector may have hit bottom and be ready for a recovery.
Avecia has scored a world first with the certification by all European Union member states of its DNA medicines production facility at Grangemouth, Scotland.
CIMA Labs has licensed its orally-disintegrating tablet formulation of fentanyl for breakthrough cancer pain to Japan's Taiho Pharmaceutical.
Evotec OAI once again defied the difficult environment for drug discovery technology companies with a 20 per cent hike in nine-month revenues to €56.7 million. Growth was driven by the firm's ultra high-throughput screening collaboration with Pfizer,
A new exhibition scheduled to take place in Hyderabad, India, in early 2005 claims to be the first to bring domestic and international chemical companies to the same forum.